Photocure ASA (PHO) – Strategy, SWOT and Corporate Finance Report

Photocure ASA (PHO) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Photocure ASA (Photocure) is a specialty pharmaceutical company with a focus on bladder cancer. It develops and markets pharmaceuticals for the diagnosis and treatment of bladder cancer and precancerous conditions based on its photodynamic technology. Photocure’s pipeline products include Cevira, a photodynamic drug-device combination product in the Phase II clinical studies for the treatment of HPV infection and precancerous lesions of the cervix. The company sells products directly through its own specialty and medical teams in the US and Nordic and through partnerships with Juno Pharmaceuticals and BioSyent Pharma.in Canada and Australia, New Zealand. Photocure is headquartered in Oslo, Norway.

Scope

• Detailed information on Photocure ASA required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Photocure ASA in the form of a SWOT analysis

• An in-depth view of the business model of Photocure ASA including a breakdown and examination of key business segments

• News about Photocure ASA, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Photocure ASA and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Photocure ASA as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Photocure ASAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Navamedic ASA

ProBio Nutraceuticals AS

ArcticZymes Technologies ASA

Nel ASA

Aqua Bio Technology ASA

Medistim ASA

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Photocure ASA - Key Facts

Photocure ASA - Key Employees

Photocure ASA - Key Employee Biographies

Photocure ASA - Major Products and Services

Photocure ASA - History

Photocure ASA - Company Statement

Photocure ASA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Photocure ASA - Business Description

Business Segment: Commercial Franchise

Overview

Performance

Business Segment: Development Portfolio

Overview

Performance

Geographical Segment: Austria

Performance

Geographical Segment: BeNeLux

Performance

Geographical Segment: Canada

Performance

Geographical Segment: France

Performance

Geographical Segment: Germany

Performance

Geographical Segment: Italy

Performance

Geographical Segment: Nordic countries

Performance

Geographical Segment: Other European Countries

Performance

Geographical Segment: Partner Countries Rest of World

Performance

Geographical Segment: The UK

Performance

Geographical Segment: The US

Performance

R&D Overview

Photocure ASA - Corporate Strategy

Photocure ASA - SWOT Analysis

SWOT Analysis - Overview

Photocure ASA - Strengths

Photocure ASA - Weaknesses

Photocure ASA - Opportunities

Photocure ASA - Threats

Photocure ASA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Photocure ASA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Photocure ASA, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 10, 2023: Photocure announces results for the first quarter of 2023

May 04, 2023: Photocure ASA - Correction: Annual general meeting held

Apr 12, 2023: Photocure ASA - Notice of the Annual General Meeting 3 May 2023

Apr 12, 2023: Photocure ASA: Annual Report 2022

Feb 23, 2023: Photocure Announces Results for the fourth quarter of 2022

Feb 20, 2023: Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC

Feb 16, 2023: Photocure Invitation to presentation of 4th quarter and preliminary full year 2022 financial results

Nov 02, 2022: Photocure Announces Results for the third quarter of 2022

Oct 25, 2022: Photocure Announces Invitation to presentation of third quarter 2022 financial results

Sep 01, 2022: Photocure appoints Anders Neijber, MD, PhD as Chief Medical Officer, Global Medical Affairs and Clinical Development

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Photocure ASA, Key Facts

Photocure ASA, Key Employees

Photocure ASA, Key Employee Biographies

Photocure ASA, Major Products and Services

Photocure ASA, History

Photocure ASA, Subsidiaries

Photocure ASA, Key Competitors

Photocure ASA, Ratios based on current share price

Photocure ASA, Annual Ratios

Photocure ASA, Annual Ratios (Cont…1)

Photocure ASA, Annual Ratios (Cont…2)

Photocure ASA, Interim Ratios

Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Photocure ASA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Photocure ASA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Photocure ASA, Performance Chart (2018 – 2022)

Photocure ASA, Ratio Charts

Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Photocure ASA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports